Publication:
Effects of whey protein, omega-3 fatty acid and Roux-en-Y gastric bypass on body weight, biochemical parameters and organ functions in an obese rat model: experimental research

dc.contributor.coauthorMert-Biberoglu, Fatma
dc.contributor.coauthorErdem, Nihal Zekiye
dc.contributor.coauthorOzdenkaya, Yasar
dc.contributor.coauthorOzdemir, Ekrem Musa
dc.contributor.departmentSchool of Medicine
dc.contributor.kuauthorSaka, Burcu
dc.contributor.schoolcollegeinstituteSCHOOL OF MEDICINE
dc.date.accessioned2024-12-29T09:39:13Z
dc.date.issued2023
dc.description.abstractPurpose Extreme obesity (EO) is one of the biggest public health problems in the world and has grown considerably over the years. The aim of the study is to examine the effect of Roux-en-Y gastric bypass (RYGB), whey protein (WP), and omega-3 polyunsaturated fatty acid (PUFA) supplementation applied to EO rats on weight loss, histopathological changes in internal organs and biochemical alterations.Materials and Methods Wistar albino female rats (n = 28) were used in the study and randomly divided into four groups. All rats were made obese by adding high fructose corn syrup (HFCS) to their drinking water. After the EO, WP and omega-3 PUFA supplementation was given and RYGB process was applied. At the end of the study, glucose, total cholesterol, HDL, VLDL, AST, ALT and uric acid changes and liver, kidney and pancreatic tissues were evaluated histopathologically.Results WP and omega-3 PUFA supplementation decreased body weight (p > 0.05). Omega-3 PUFA and RYGB caused a decrease in total cholesterol (p < 0.05), WP decreased HDL (p < 0.05), WP and omega-3 PUFA caused an increase in ALT (p < 0.05). WP has been shown to have greater curative effects in rat liver and kidney tissues. It has been determined that RYGB causes necrosis in the liver and HFCS causes inflammation in the kidney.Conclusion In the study; the positive effects of WP, omega-3 PUFA and bariatric surgery on obesity and dyslipidemia have been demonstrated. With this result, it was determined that WP, omega-3 PUFA supplementation and bariatric surgery were not superior to each other.
dc.description.indexedbyWOS
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.issue5
dc.description.openaccess 
dc.description.publisherscopeInternational
dc.description.sponsoredbyTubitakEuN/A
dc.description.sponsorship 
dc.description.volume33
dc.identifier.doi10.1007/s11695-023-06560-z
dc.identifier.eissn1708-0428
dc.identifier.issn0960-8923
dc.identifier.link 
dc.identifier.quartileQ1
dc.identifier.scopus2-s2.0-85150949050
dc.identifier.urihttps://doi.org/10.1007/s11695-023-06560-z
dc.identifier.urihttps://hdl.handle.net/20.500.14288/22941
dc.identifier.wos960207000001
dc.keywordsExtreme obesity
dc.keywordsOmega-3 PUFA
dc.keywordsRoux-en-Y gastric bypass
dc.keywordsWhey protein
dc.language.isoeng
dc.publisherSpringer
dc.relation.grantno 
dc.relation.ispartofObesity Surgery
dc.rights 
dc.subjectSurgery
dc.titleEffects of whey protein, omega-3 fatty acid and Roux-en-Y gastric bypass on body weight, biochemical parameters and organ functions in an obese rat model: experimental research
dc.typeJournal Article
dc.type.other 
dspace.entity.typePublication
local.contributor.kuauthorSaka, Burcu
local.publication.orgunit1SCHOOL OF MEDICINE
local.publication.orgunit2School of Medicine
relation.isOrgUnitOfPublicationd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isOrgUnitOfPublication.latestForDiscoveryd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isParentOrgUnitOfPublication17f2dc8e-6e54-4fa8-b5e0-d6415123a93e
relation.isParentOrgUnitOfPublication.latestForDiscovery17f2dc8e-6e54-4fa8-b5e0-d6415123a93e

Files